Pharma Mar (OTCMKTS:PHMMF – Get Free Report) shares hit a new 52-week high on Friday . The stock traded as high as $110.40 and last traded at $110.40, with a volume of 400 shares trading hands. The stock had previously closed at $102.25.
Pharma Mar Stock Up 8.0%
The company has a debt-to-equity ratio of 0.20, a quick ratio of 2.33 and a current ratio of 2.97. The business’s 50 day moving average price is $97.09 and its 200-day moving average price is $93.88.
Pharma Mar Company Profile
Pharma Mar, SA, a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally. The company operates through Oncology and RNA Interference segments.
Further Reading
- Five stocks we like better than Pharma Mar
- Canada Bond Market Holiday: How to Invest and Trade
- Why the Precious Metal Nobody Talks About Could Be Your Best Bet
- How to Short Nasdaq: An Easy-to-Follow Guide
- Cheap Chipotle? Why CMG Stock Could Be Ready for a Comeback
- Why Invest in 5G? How to Invest in 5G Stocks
- 3 Industrial Stocks Ready to Benefit From Fed Cuts and Spending
Receive News & Ratings for Pharma Mar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharma Mar and related companies with MarketBeat.com's FREE daily email newsletter.
